Icagen Rises on M&A Speculation with Pfizer -AP

by Patrick Henderson, Benzinga Staff Writer
June 27, 2011 8:06 AM | 17 seconds read |
The Associated Press reports that Icagen ICGN is rising on merger speculation with Pfizer PFE. The Reuters story on the AP article can be found via the link above. At last check, shares of Icagen were trading over 133% higher in pre-market trading versus Friday's closing price.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: RumorsSmall Cap AnalysisM&AMoversBiotechnologyHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!